SATIATION
Unknown
150 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation
Unknown
250 enrolled
The Bacterial Composition of the Stomach in Reflux Disease
Unknown
100 enrolled
GESOM
Unknown
30 enrolled
Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning
Unknown
50 enrolled
Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis
Unknown
562 enrolled
Prediction Model of Response for CCRT in Esophageal Cancer
Unknown
140 enrolled
Risk Factors of Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to Neoadjuvant Chemoradiotherapy
Unknown
96 enrolled
RARESTEM/Org
Unknown
100 enrolled
Follow-up Strategy for Esophageal Cancer Patients
Unknown
3,000 enrolled
PC-TOX
Unknown
75 enrolled
SECC
Unknown
616 enrolled
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Unknown
220 enrolled
NEED
Unknown
1,000 enrolled
VERVE
Unknown
35 enrolled
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
Unknown
60 enrolled
CADENCE
Unknown
15,000 enrolled
The Microbiome of Oesophageal Squamous Cell Carcinoma
Unknown
200 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
CONDOR-I
Unknown
30 enrolled
QARC
Unknown
150 enrolled
POSITRON
Unknown
100 enrolled
RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA: AN OBSERVATIONAL STUDY
Unknown
1,600 enrolled
SOEGAS
Unknown
25,000 enrolled
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy
Unknown
150 enrolled
Computational Prediction and Experimental Validation of Esophageal Cancer Associated Neoantigens
Unknown
50 enrolled
Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection
Unknown
3,591 enrolled
PROFUGO
Unknown
800 enrolled
AIPAAIAEC
Unknown
300 enrolled
RAILE
Unknown
51 enrolled
Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt
Unknown
2,000 enrolled
APEC
Unknown
50 enrolled
Anlotinib for Esophageal Cancer (AFEC)
Unknown
200 enrolled
EsoLeak
Unknown
40 enrolled
PROSPERO
Unknown
1,000 enrolled
Heartcheck
Unknown
56 enrolled
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
Unknown
150 enrolled
Genomic Study of Relapse Esophageal Cancer After Radiotherapy
Unknown
200 enrolled
PIONEER
Unknown
1,000 enrolled
PRIDE
Unknown
200 enrolled
CURE
Unknown
1,950 enrolled
NC-ESD
Unknown
300 enrolled
HEAGIS2
Unknown
50 enrolled
WATTOX
Unknown
50 enrolled
The Application of 3T MRI in Esophageal Cancer
Unknown
400 enrolled
Study to Evaluate the Safety of Nanoxel M Inj.
Unknown
1,498 enrolled
MA-PPING
Unknown
60 enrolled
Classification of Adenocarcinoma of the Esophagogastric Junction
Unknown
1,658 enrolled
Cryotherapy
Unknown
50 enrolled